Sana Biotechnology, Inc. SEC filings SANA

Sana Biotechnology, Inc. has 389 filings in SEC EDGAR's recent list, going back to Jun 26, 2020. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Sana Biotechnology, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 6, 2026 Oct 5, 2026
8-K Current report
Regulation FD disclosure
Sep 8, 2026 Sep 8, 2026
4 Insider transaction Aug 27, 2026 Aug 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
4 Insider transaction Jul 7, 2026 Jul 6, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
8-K Current report
Shareholder vote results
Jun 5, 2026 Jun 4, 2026
SCHEDULE 13G Ownership over 5% (passive) May 21, 2026 —
8-K Current report
Other events
May 15, 2026 May 15, 2026
S-8 Employee stock plan registration May 11, 2026 —
10-Q Quarterly report May 11, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 4, 2026
8-K Current report
Officer or director change
Apr 24, 2026 Apr 22, 2026
424B5 Prospectus supplement Apr 13, 2026 —
8-K Current report
Other events
Apr 13, 2026 Apr 10, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
3 Initial insider ownership Mar 27, 2026 Mar 24, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 6, 2026 Mar 5, 2026
4 Insider transaction Mar 6, 2026 Mar 5, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
S-3ASR Automatic shelf registration Mar 3, 2026 —
10-K Annual report Mar 3, 2026 Dec 31, 2025
8-K Current report
Results of operations, Other events
Mar 3, 2026 Mar 3, 2026
4 Insider transaction Feb 18, 2026 Feb 17, 2026
3 Initial insider ownership Feb 18, 2026 Feb 17, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 17, 2026 Feb 17, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 21, 2026 —
8-K Current report
Regulation FD disclosure
Jan 14, 2026 Jan 14, 2026
4 Insider transaction Jan 6, 2026 Jan 5, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Dec 16, 2025 Dec 13, 2025
4 Insider transaction Dec 5, 2025 Dec 13, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
4 Insider transaction Oct 7, 2025 Oct 6, 2025
UPLOAD Letter from the SEC Sep 10, 2025 —
8-K Current report
Officer or director change, Other events
Sep 5, 2025 Sep 4, 2025
8-K Current report
Officer or director change
Aug 29, 2025 Aug 28, 2025
CORRESP Letter to the SEC Aug 13, 2025 —
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
8-K Current report
Material agreement, Other events
Aug 7, 2025 Aug 6, 2025
424B5 Prospectus supplement Aug 7, 2025 —
424B5 Prospectus supplement Aug 6, 2025 —
8-K Current report
Results of operations, Other events
Aug 6, 2025 Aug 6, 2025
UPLOAD Letter from the SEC Jul 30, 2025 —
4 Insider transaction Jul 8, 2025 Jul 7, 2025
8-K Current report
Other events
Jun 23, 2025 Jun 23, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
3 Initial insider ownership Jun 9, 2025 Jun 5, 2025
8-K Current report
Shareholder vote results
Jun 6, 2025 Jun 5, 2025
424B5 Prospectus supplement May 8, 2025 —
S-8 Employee stock plan registration May 8, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations, Other events
May 8, 2025 May 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 25, 2025 —
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 5, 2025
4 Insider transaction Apr 8, 2025 Apr 7, 2025
EFFECT Filing Mar 21, 2025 —
POS AM Filing Mar 17, 2025 —
10-K Annual report Mar 17, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 17, 2025 Mar 17, 2025
POSASR Filing Mar 14, 2025 —
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 3, 2025 Mar 2, 2025
144 Notice of proposed sale Feb 18, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 31, 2025 —
144 Notice of proposed sale Jan 16, 2025 —
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Jan 10, 2025 Jan 8, 2025
4 Insider transaction Jan 7, 2025 Jan 6, 2025
4 Insider transaction Jan 3, 2025 Jan 2, 2025
144 Notice of proposed sale Dec 16, 2024 —
144 Notice of proposed sale Nov 26, 2024 —
144 Notice of proposed sale Nov 25, 2024 —
3/A Filing Nov 21, 2024 Apr 1, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 8, 2024 Nov 8, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
SC 13G Ownership over 5% (passive) Oct 22, 2024 —
144 Notice of proposed sale Oct 21, 2024 —
3 Initial insider ownership Oct 15, 2024 Oct 4, 2024
4 Insider transaction Oct 9, 2024 Oct 7, 2024
8-K Current report
Officer or director change
Oct 8, 2024 Oct 4, 2024
4 Insider transaction Sep 26, 2024 Sep 24, 2024
144 Notice of proposed sale Sep 25, 2024 —
144 Notice of proposed sale Sep 24, 2024 —
8-K Current report
Officer or director change
Sep 12, 2024 Sep 6, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
4/A Primary document Jul 15, 2024 Jun 6, 2024
4/A Primary document Jul 15, 2024 Jun 6, 2024
4/A Primary document Jul 15, 2024 Jun 6, 2024
4/A Primary document Jul 15, 2024 Jun 6, 2024
4/A Primary document Jul 15, 2024 Jun 6, 2024
4/A Primary document Jul 15, 2024 Jun 6, 2024
4/A Primary document Jul 15, 2024 Jun 6, 2024
4/A Primary document Jul 15, 2024 Jun 6, 2024
4/A Primary document Jul 15, 2024 Jun 6, 2024
4 Insider transaction Jul 8, 2024 Jul 5, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
8-K Current report
Shareholder vote results
Jun 7, 2024 Jun 6, 2024
S-8 Employee stock plan registration May 8, 2024 —
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 6, 2024
8-K Current report
Officer or director change
Apr 18, 2024 Apr 18, 2024
4 Insider transaction Apr 8, 2024 Apr 5, 2024
3 Initial insider ownership Apr 8, 2024 Apr 1, 2024
SC 13G/A Amended ownership over 5% (passive) Apr 3, 2024 —
4 Insider transaction Mar 11, 2024 Mar 8, 2024
4 Insider transaction Mar 8, 2024 Mar 7, 2024
4 Insider transaction Mar 8, 2024 Mar 7, 2024
4 Insider transaction Mar 8, 2024 Mar 7, 2024
4 Insider transaction Mar 8, 2024 Mar 7, 2024
4 Insider transaction Mar 8, 2024 Mar 7, 2024
SC 13G/A Amended ownership over 5% (passive) Mar 7, 2024 —
S-3ASR Automatic shelf registration Mar 1, 2024 —
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 29, 2024 Feb 29, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
4 Insider transaction Feb 14, 2024 Feb 12, 2024
3 Initial insider ownership Feb 14, 2024 Feb 12, 2024
4 Insider transaction Feb 12, 2024 Feb 8, 2024
4 Insider transaction Feb 12, 2024 Feb 8, 2024
4 Insider transaction Feb 12, 2024 Feb 8, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
8-K Current report
Material agreement, Other events
Feb 8, 2024 Feb 7, 2024
424B5 Prospectus supplement Feb 8, 2024 —
FWP Free writing prospectus Feb 8, 2024 —
424B5 Prospectus supplement Feb 7, 2024 —
8-K Current report
Results of operations, Other events
Feb 7, 2024 Feb 7, 2024
SC 13G/A Amended ownership over 5% (passive) Jan 26, 2024 —
8-K Current report
Regulation FD disclosure
Jan 9, 2024 Jan 9, 2024
4 Insider transaction Jan 8, 2024 Jan 5, 2024
4 Insider transaction Jan 8, 2024 Jan 5, 2024
4 Insider transaction Dec 18, 2023 Dec 15, 2023
144 Notice of proposed sale Dec 15, 2023 —
8-K Current report
Regulation FD disclosure
Dec 11, 2023 Dec 11, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
4 Insider transaction Nov 3, 2023 Nov 2, 2023
4 Insider transaction Nov 3, 2023 Nov 2, 2023
4 Insider transaction Nov 3, 2023 Nov 2, 2023
8-K Current report
Exit or restructuring costs, Regulation FD disclosure
Oct 10, 2023 Oct 10, 2023
4 Insider transaction Oct 6, 2023 Oct 5, 2023
4 Insider transaction Oct 6, 2023 Oct 5, 2023
4 Insider transaction Sep 15, 2023 Sep 13, 2023
8-K Current report
Regulation FD disclosure
Sep 13, 2023 Sep 12, 2023
8-K Current report
Agreement ended
Aug 21, 2023 Aug 17, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
4 Insider transaction Jul 6, 2023 Jul 5, 2023
4 Insider transaction Jul 6, 2023 Jul 5, 2023
4 Insider transaction Jun 12, 2023 Jun 8, 2023
4 Insider transaction Jun 9, 2023 Jun 8, 2023
4 Insider transaction Jun 9, 2023 Jun 8, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
SANA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Seattle, WA
SEC filer status
, Emerging growth company
SEC CIK
1770121

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.